Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Syngene International Ltd. ( (IN:SYNGENE) ).
Syngene International Limited has announced its 32nd Annual General Meeting (AGM) scheduled for July 23, 2025, to be held via video conferencing. Key agenda items include the adoption of audited financial statements for the fiscal year ending March 31, 2025, the declaration of a final dividend of Rs. 1.25 per equity share, and the reappointment of Professor Catherine Rosenberg as a director. Additionally, the company plans to appoint M/s V Sreedharan & Associates as secretarial auditors and recommend Ms. Vinita Bali as a Non-Executive Director. These decisions are poised to impact the company’s governance and financial distribution strategy, reflecting its commitment to shareholder engagement and corporate compliance.
More about Syngene International Ltd.
Syngene International Limited operates in the biotechnology industry, providing integrated research, development, and manufacturing services. The company focuses on offering solutions across various sectors, including pharmaceuticals, biotechnology, and agrochemicals, leveraging its expertise in drug discovery, development, and manufacturing.
Average Trading Volume: 38,990
Current Market Cap: 259.2B INR
See more insights into SYNGENE stock on TipRanks’ Stock Analysis page.